Novonesis welcomes the Circular Economy Act (CEA) which will be a driving force in accelerating Europes transition towards a more sustainable, resource-efficient, and competitive economy. We note the importance of ensuring that the CEA takes a holistic approach to circularity.
NOV
Novonesis
Company · Denmark · EU Transparency Register 780717547356-52
16
positions filed
in the 665 files tracked
12
legislative files
of 665 tracked
13
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1210 companies & groups on this site, they rank #94 by legislative files engaged, a count of participation, not a measure of influence.
4
declared lobbying FTE
self-declared
€700K+
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2022
in the register since
Declares membership of
- https://www.epure.org/
- https://biconsortium.eu/
- https://www.europabio.org/
- https://www.danskindustri.dk/
- https://amfep.org/
- https://fefana.org/
- https://www.ewaba.eu/
- https://effca.org/
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Companies & groups
- Registered as
- Novonesis A/S (Novonesis)
- Head office
- Lyngby, Denmark
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Novonesis in PolicySpeak: request access →
Work at Novonesis? so we know who speaks for it.
Their record over time
Novonesis filed 16 positions between 8 Nov 2021 and 16 Sept 2026, across 12 of the 665 legislative files tracked here, attaching a full position paper 13 times.
2021 · 2 filed2022 · 1 filed2023 · 1 filed2024 · 2 filed2025 · 3 filed2026 · 7 filed
What they argued
Novonesis welcomes the opportunity to contribute to the public consultation on the Industrial Accelerator Act. We support the Acts objective of strengthening Europes industrial base while accelerating decarbonisation, and we believe it can make an important contribution to the Unions resilience, competitiveness, economic security and strategic autonomy.
Novonesis welcomes the Commissions initiative to develop the Industrial Decarbonisation Accelerator Act (IDAA), which represents a crucial step towards enabling energy-intensive industries (EIIs) to decarbonise while maintaining European competitiveness.
Novonesis welcomes the European Commission proposal COM(2025) 1031 which is a step towards a more proportionate and risk-based application of EU GMO legislation. It is positive that the proposal takes steps towards a lighter regime for genetically modified microorganisms (GMMs) with a demonstrably low-risk profile.
Novonesis strongly supports the Commissions intention to develop an EU Biotech Act that aims to address the challenges and barriers faced by biotechnology across several sectors (including agriculture, food and feed, environment, and industry). The upcoming Biotech Act is Europes best chance to chart a new course for the biosolutions sector.
Novonesis strongly supports the Commissions intention to develop an EU Biotech Act II that aims to strengthen Europes biotechnology and biomanufacturing base and enable the EU to become a global leader in safe, sustainable and competitive biotech innovation.
Our organisation welcomes the growing political momentum behind the upcoming Biotech Act II and sees it as a critical opportunity to strengthen Europes competitiveness and resilience. From our perspective, the priority is to ensure a framework that enables biosolutions to scale.
Novonesis welcomes the European Commissions initiative to develop an updated framework for renewable energy, electrification, and energy system integration. The ambition to strengthen Europes competitiveness, security of supply, and progress toward the 2040 climate target is both timely and essential.
Novozymes welcomes and supports the Commissions initiative to modernize the GMO Directive, starting with plants produced by targeted mutagenesis and cisgenesis. We indeed agree with the conclusions in the Commissions study on the status of new genomic techniques, confirming that the current regulatory system involves implementation and enforcement challenges in the EU.
Novonesis and Carbios welcome the European Commission's initiative to establish sustainability criteria for plastic recycling technologies under the Packaging and Packaging Waste Regulation. Setting a clear and science-based framework for how recycling technologies are assessed is essential if Europe is to meet the recycled-content targets of the PPWR, strengthen the circularity and competitiveness of its plastics…
Novozymes welcomes the Commission’s proposal to implement dedicated legislations for the decarbonization of aviation through sustainable renewable fuels but strongly objects to the decision to exclude or penalize biofuels produced from food and feed crops.
Novozymes welcomes the Commission’s proposal to implement dedicated legislations for the decarbonization of maritime through sustainable renewable fuels but strongly objects to the ill-founded decision to exclude or penalize biofuels produced from food and feed crops.
Novonesis is supportive of the intention behind the One Substance, One Assessment initiative. Novonesis supports the European Commissions ambition about streamlining of substances across EU legislations and strengthening the knowledge about substances and act on new chemical risks when they occur. This initiative will make better risk assessment and increase transparency for consumers and researchers.
Novonesis is supportive of the intention behind the One Substance, One Assessment initiative. Novonesis supports the European Commissions ambition about streamlining of substances across EU legislations and strengthening the knowledge about substances and act on new chemical risks when they occur. This initiative will make better risk assessment and increase transparency for consumers and researchers.
Novozymes welcomes the opportunity to provide feedback to the Commission’s call for evidence on chemicals – making best use of EU agencies to streamline scientific assessments. Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet’s resources and helping to build better lives.
The 2025 Strategic Foresight Report highlights biotechnology several times as a transformative technology area with the potential to strengthen Europes economic resilience, strategic autonomy, and green transition. Building on this foundation, the 2026 report provides an opportunity dive deeper and elevate biosolutions and biomanufacturing as a strategic priority.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Novonesis next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 459.
Is this your organization?
Everything on this page comes from Novonesis’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.